Ansuvimab Medication Information

Discover comprehensive details about Ansuvimab, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it.

The updated prescription information covers potential side effects, precautions, warnings, and storage recommendations.

Additionally, explore the Ansuvimab brands available in India and internationally, along with pricing information. For personalized advice, consult your healthcare provider.

Generic Name : Ansuvimab

Pronunciation : an SOO vi mab

Brand Names or Trade Names of Ansuvimab

India :

Ebanga

Overview of Ansuvimab

Ansuvimab is indicated for the treatment of infection caused by Zaire ebolavirus in adults and kids, including newborns of mothers who are RT-PCR positive for Zaire ebolavirus infection.

Why is Ansuvimab Prescribed? (Indications)

Ansuvimab is a monoclonal antibody prescribed for treating Zaire ebolavirus infection. This virus can change over time and there is high chance of emergence of resistance.

When should Ansuvimab not be taken? (Contraindications)

• Allergic to Ansuvimab
• Pregnancy
• Children aged below 18 years
• Adults aged above 65 years

What is the dosage of Ansuvimab?

It is available as injection: 400 mg lyophilized powder in a single-dose vial for reconstitution and further dilution. Dose should be calculated based on the patient’s actual weight in kg.

How should Ansuvimab be taken?

The recommended dose is 50 mg/kg reconstituted. It is administered as a single intravenous infusion over 60 minutes.
It should be reconstituted with sterile water for injection, then further diluted in 0.9% Sodium Chloride injection. Before reconstitution, allow the vial to reach ambient temperature (15°C to 27°C [59°F to 81°F]) for 20 minutes.
The diluted IV solution can be infused via a central line or peripheral catheter. It should not be given as an IV push or bolus.

What are the side effects of Ansuvimab?

• General: Fever, chills
• Cardiovascular:-ore heart rate Rapid heartbeat (Tachycardia), Low blood pressure
• Gastrointestinal: Diarrhea, Vomiting
• Respiratory system: Increased respiratory rate

What are the other precautions for Ansuvimab?

• Ansuvimab may cause allergic reactions including infusion-related events, which may be acute, life-threatening reactions during and after the infusion. In case of severe or life-threatening hypersensitivity reactions, discontinue the administration immediately and seek appropriate emergency care.
• Patients infected with Zaire ebolavirus should not breastfed.